SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-029594
Filing Date
2023-04-13
Accepted
2023-04-13 17:24:34
Documents
12
Period of Report
2023-04-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea176929-8k_enzo.htm   iXBRL 8-K 30105
  Complete submission text file 0001213900-23-029594.txt   201717

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE enz-20230406.xsd EX-101.SCH 2944
3 XBRL LABEL FILE enz-20230406_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE enz-20230406_pre.xml EX-101.PRE 22350
6 EXTRACTED XBRL INSTANCE DOCUMENT ea176929-8k_enzo_htm.xml XML 3484
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 23819203
SIC: 8071 Services-Medical Laboratories